Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.

MLA

Lin, Pengcheng, et al. “Diagnostic Value of Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid for the Diagnosis of Suspected Pneumonia in Immunocompromised Patients.” BMC Infectious Diseases, vol. 22, no. 1, Apr. 2022, p. 416. EBSCOhost, https://doi.org/10.1186/s12879-022-07381-8.

APA

Lin, P., Chen, Y., Su, S., Nan, W., Zhou, L., Zhou, Y., & Li, Y. (2022). Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients. BMC Infectious Diseases, 22(1), 416. https://doi.org/10.1186/s12879-022-07381-8

Chicago

Lin, Pengcheng, Yi Chen, Shanshan Su, Wengang Nan, Lingping Zhou, Ying Zhou, and Yuping Li. 2022. “Diagnostic Value of Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid for the Diagnosis of Suspected Pneumonia in Immunocompromised Patients.” BMC Infectious Diseases 22 (1): 416. doi:10.1186/s12879-022-07381-8.